A study suggested that of the most common FGFR3 mutation in about 65% of bladder cancer is caused by APOBEC, and APOBEC mutation signature plays an important biological role in bladder cancer [15]. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.